USANA HEALTH SCIENCES INC

USNA

USANA HEALTH SCIENCES INC

USNA

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-16Shares Purchased (TTM):0Shares Sold (TTM):53,941

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:10,022,829Shares Outstanding:18,398,000Institutional Ownership Pct.:54.48%

Earnings Market Reaction:

Filing Date:2026-05-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Medicinal Chemicals & Botanical Products

DFTX TCNNF CRON TLRY NAGE CGC

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	163	158	145	151	180	182	365	332	328	330	307	300
Receivables Net Current	10	-	-	-	-	-	-	-	-	-	-	-
Inventory Net	96	103	91	83	74	70	64	62	61	61	60	62
Prepaid Expense And Other Assets Current	25	27	28	27	28	28	22	25	32	26	23	26
Assets Current	294	288	264	262	281	279	451	419	421	418	390	388
Property Plant And Equipment Net	95	94	96	97	94	95	98	98	98	100	95	96
Goodwill	138	138	144	144	144	144	17	17	17	17	17	17
Intangible Assets Net Excluding Goodwill	129	133	138	143	147	152	29	29	29	30	29	30
Deferred Income Tax Assets Net	25	27	24	26	19	20	17	18	11	13	15	16
Other Assets Noncurrent	58	62	60	63	61	59	59	51	53	55	54	57
Assets	739	743	727	735	747	748	671	631	629	633	601	603
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	16	17	16	18	14	12	7	7	8	10	9	9
Lines Of Credit Current	14	14	0	0	23	23	0	0	1	1	-	-
Other Liabilities Current	87	97	102	104	100	105	108	97	103	108	103	105
Liabilities Current	117	129	119	122	137	140	115	104	113	119	113	114
Deferred Income Tax Liabilities Net	5	5	4	5	5	4	5	5	5	5	5	5
Other Liabilities Noncurrent	22	23	22	23	21	18	19	11	12	12	13	15
Liabilities	144	157	145	149	163	162	-	-	-	136	-	-
Redeemable Noncontrolling Interest Equity Carrying…	51	53	53	54	54	54	-	-	-	0	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	85	84	80	76	75	76	72	69	65	66	62	60
Retained Earnings Accumulated Deficit	473	466	467	474	478	479	474	464	453	445	428	427
Accumulated Other Comprehensive Income Loss Net Of…	-14	-16	-19	-19	-23	-23	-14	-21	-19	-14	-20	-18
Stockholders Equity	544	533	528	531	530	532	533	512	500	497	470	469
Liabilities And Stockholders Equity	739	743	727	735	747	748	671	631	629	633	601	603
Allowance For Doubtful Other Receivables Current	0	-	-	-	-	-	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Common Stock Shares Issued	18	18	18	18	19	19	19	19	19	19	19	19
Shares Outstanding	18	18	18	18	19	19	19	19	19	19	19	19

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.86%	23.91%	-	-	-	-	-	-	-	-	-	-
2025	4.92%	9.34%	12.22%	10.57%	-1.14%	-27.93%	-2.74%	-2.79%	10.39%	3.25%	8.10%	2.79%
2024	6.39%	1.12%	-4.74%	3.34%	-4.00%	-6.81%	-1.15%	-8.44%	-11.90%	-21.62%	-9.44%	-8.12%
2023	-	-	-	-2.60%	-11.80%	-32.42%	4.87%	16.95%	5.93%	-0.62%	-8.31%	1.79%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.51	2.24	2.23	2.15	2.05	2.00	3.93	4.03	3.74	3.52	3.47	3.41
Quick Ratio	1.47	1.23	1.22	1.24	1.31	1.30	3.18	3.20	2.92	2.78	2.73	2.64
Working Capital	176.99M	159.84M	145.40M	140.24M	144.01M	139.56M	336.41M	315.19M	308.44M	298.90M	277.90M	273.81M
Leverage & Debt
Debt to Equity	0.27	0.29	0.27	0.28	0.31	0.30	0.22	0.20	0.23	0.27	0.24	0.24
Interest Coverage TTM	53.11	44.46	49.32	66.27	89.57	236.03	251.02	261.92	321.20	355.23	609.35	693.71
Debt Ratio	0.20	0.21	0.20	0.20	0.22	0.22	0.17	0.16	0.18	0.21	0.19	0.19
Efficiency & Turnover
Asset Turnover TTM	1.25	1.24	1.31	1.32	1.27	1.24	1.35	1.42	1.46	1.50	1.60	1.63
Days Sales Outstanding TTM	3.81	-	-	-	-	-	-	-	-	-	-	-
Receivables Turnover TTM	95.88	-	-	-	-	-	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	0.45	0.58	0.93	1.84	1.83	2.19	2.85	2.87	3.21	3.30	3.09	3.26
Free Cash Flow Per Share TTM	0.16	0.46	1.02	2.75	2.58	2.67	3.44	3.11	3.12	2.92	3.88	4.11
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	77.55%	78.29%	79.18%	79.93%	80.53%	81.13%	80.86%	80.77%	80.98%	80.82%	80.51%	80.50%
Operating Profit Margin TTM	3.85%	4.05%	4.58%	6.25%	6.54%	7.76%	9.55%	9.64%	10.09%	10.11%	9.85%	10.17%
Net Profit Margin TTM	0.90%	1.16%	1.86%	3.79%	3.98%	4.92%	6.30%	6.29%	6.88%	6.93%	6.45%	6.69%
Growth Metrics
Net Revenue Growth (1Y)	5.67%	8.28%	5.88%	2.75%	-2.69%	-7.22%	-7.10%	-7.67%	-7.56%	-7.77%	-10.60%	-12.16%
Net Income Growth (1Y)	-76.17%	-74.40%	-68.74%	-38.06%	-43.67%	-34.11%	-9.15%	-13.12%	-5.09%	-8.02%	-22.19%	-28.99%
EPS Growth (1Y)	-75.32%	-73.61%	-67.40%	-36.19%	-43.30%	-33.60%	-8.36%	-11.99%	-4.55%	-8.00%	-22.29%	-29.37%
Valuation Metrics
P/E TTM	38.65	33.81	29.66	16.57	14.72	16.31	13.31	15.67	15.01	16.18	18.86	19.21
P/B TTM	0.59	0.68	0.95	1.06	0.97	1.29	1.36	1.68	1.86	2.08	2.40	2.60
P/S TTM	0.35	0.39	0.55	0.63	0.59	0.80	0.84	0.99	1.03	1.12	1.22	1.29
Market Cap	321.41M	363.84M	503.97M	565.20M	513.75M	685.61M	723.44M	862.86M	929.94M	1.03B	1.13B	1.22B
Enterprise Value	172.66M	219.46M	355.82M	413.86M	354.38M	524.10M	355.70M	527.69M	602.92M	702.17M	820.87M	915.05M
Calculated Values
Free Cash Flow TTM	2.96M	8.53M	18.69M	50.99M	49.12M	50.92M	65.64M	59.28M	59.90M	56.15M	74.63M	79.39M
Net Debt	-148.75M	-144.38M	-148.15M	-151.34M	-159.37M	-161.51M	-367.74M	-335.18M	-327.02M	-329.63M	-307.08M	-302.94M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-16Sale

Owner: Neidig, Brent

Title: CHIEF COMMERCIAL OFFICER

Shares: 5,002

Price/Share: $19.45

Value: $97,288.90

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-06-15Sale

Owner: Neidig, Brent

Title: CHIEF COMMERCIAL OFFICER

Shares: 909

Price/Share: $20.01

Value: $18,189.09

Shares Owned: 5,002

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Jones, Paul A.

Title: CHIEF PEOPLE OFFICER

Shares: 5,561

Price/Share: $18.50

Value: $102,878.50

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Fleming, John Turman

Title: -

Shares: 2,450

Price/Share: $17.93

Value: $43,928.50

Shares Owned: 4,230

Relationship: Director

Ownership: Direct

2026-05-28Sale

Owner: Jones, Paul A.

Title: CHIEF PEOPLE OFFICER

Shares: 6,813

Price/Share: $18.95

Value: $129,106.35

Shares Owned: 5,561

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-16	Neidig, Brent	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	5,002	19.45	$97,288.90	0	4
2026-06-15	Neidig, Brent	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	909	20.01	$18,189.09	5,002	4
2026-06-08	Jones, Paul A.	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	5,561	18.50	$102,878.50	0	4
2026-06-01	Fleming, John Turman	Director	-	Direct	Sale	2,450	17.93	$43,928.50	4,230	4
2026-05-28	Jones, Paul A.	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	6,813	18.95	$129,106.35	5,561	4
2026-05-27	Iiekking, G Doug	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	5,360	18.75	$100,500.00	0	4
2026-05-22	Fuller, Gilbert A	Director	-	Direct	Sale	1,057	18.66	$19,723.62	0	4
2026-05-07	Foukas, Joshua	Officer	CHIEF LEGAL OFFICER	Direct	Sale	3,791	19.82	$75,137.62	0	4
2026-03-20	Fuller, Gilbert A	Director	-	Direct	Sale	1,058	17.00	$17,986.00	0	4
2026-03-03	Benedict, Peter	Officer	CHIEF INFORMATION OFFICER	Direct	Sale	4,553	19.38	$88,237.14	0	4
2026-02-20	Foukas, Joshua	Officer	CHIEF LEGAL OFFICER	Direct	Sale	4,461	21.35	$95,242.35	0	4
2025-12-10	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	873	21.00	$18,333.00	8,387	4
2025-12-10	Benedict, Peter	Officer	CHIEF INFORMATION OFFICER	Direct	Sale	2,673	20.95	$55,999.35	0	4
2025-11-10	Winssinger, Frederic J	Director	-	Direct	Sale	2,000	19.21	$38,420.00	5,986	4
2025-11-03	Fuller, Gilbert A	Director	-	Direct	Sale	1,057	21.48	$22,704.36	0	4
2025-10-31	Fleming, John Turman	Director	-	Direct	Sale	1,750	19.79	$34,632.50	4,565	4
2025-08-07	Fuller, Gilbert A	Director	-	Direct	Sale	1,058	29.10	$30,787.80	0	4
2025-07-30	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	3,515	30.26	$106,363.90	9,260	4
2025-06-09	Fleming, John Turman	Director	-	Direct	Sale	500	29.66	$14,830.00	4,200	4
2025-05-27	Noot, Walter	Officer	CHIEF OPERATING OFFICER	Direct	Sale	6,291	30.29	$190,554.39	0	4
2025-05-09	Iiekking, G Doug	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	4,548	29.61	$134,666.28	0	4
2025-05-05	Fuller, Gilbert A	Director	-	Direct	Sale	674	29.82	$20,098.68	0	4
2025-03-12	Foukas, Joshua	Officer	CHIEF LEGAL OFFICER	Direct	Sale	5,732	32.54	$186,519.28	0	4
2025-03-12	Neidig, Brent	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	4,743	32.34	$153,388.62	0	4
2025-03-11	Fleming, John Turman	Director	-	Direct	Sale	500	33.30	$16,650.00	4,026	4
2025-03-10	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	3,234	32.98	$106,657.32	12,775	4
2025-03-06	Fuller, Gilbert A	Director	-	Direct	Sale	674	31.44	$21,190.56	0	4
2025-03-03	Brown, Jim	Officer	CEO & PRESIDENT	Direct	Sale	5,000	29.47	$147,350.00	15,716	4
2025-02-27	Pelosi, Peggie	Director	-	Direct	Sale	780	28.10	$21,918.00	3,395	4
2024-11-04	Fuller, Gilbert A	Director	-	Direct	Sale	675	37.71	$25,454.25	0	4
2024-08-13	Jones, Paul A.	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	6,266	38.38	$240,489.08	0	4
2024-08-07	Fuller, Gilbert A	Director	-	Direct	Sale	674	39.69	$26,751.06	0	4
2024-07-31	Fleming, John Turman	Director	-	Direct	Sale	1,000	44.43	$44,430.00	2,503	4
2024-06-14	Wentz, Myron W, Gull Glob…	TenPercentOwner	-	Indirect	Sale	13,496	45.03	$607,724.88	7,864,345	4
2024-06-07	Wentz, Myron W, Gull Glob…	TenPercentOwner	-	Indirect	Sale	3,700	48.61	$179,857.00	7,880,043	4
2024-05-22	Jones, Paul A.	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	2,714	48.66	$132,063.24	6,266	4
2024-05-07	Fuller, Gilbert A	Director	-	Direct	Sale	490	44.59	$21,849.10	0	4
2024-05-07	Iiekking, G Doug	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	5,198	44.76	$232,662.48	0	4
2024-05-02	Macuga, Daniel A.	Officer	CHIEF COMMUNICATIONS OFFICER	Direct	Sale	3,791	47.14	$178,707.74	0	4/A
2024-03-11	Guest, Kevin	Officer	EXEC. CHAIRMAN OF THE BOARD	Direct	Sale	11,011	49.00	$539,539.00	10,491	4
2024-03-08	Noot, Walter	Officer	CHIEF OPERATING OFFICER	Direct	Sale	5,240	49.05	$257,022.00	0	4
2024-03-06	Neidig, Brent	Officer	CO. & MAN. DIR. OF CHINA	Direct	Sale	3,810	47.00	$179,070.00	0	4
2024-03-05	Sinnott, Robert A	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	3,945	46.56	$183,679.20	0	4
2024-03-04	Fleming, John Turman	Director	-	Direct	Sale	300	48.99	$14,697.00	3,013	4
2024-03-04	Fuller, Gilbert A	Director	-	Direct	Sale	491	49.07	$24,093.37	0	4
2024-03-01	Macuga, Daniel A.	Officer	CHIEF COMMUNICATIONS OFFICER	Direct	Sale	1,500	48.08	$72,120.00	3,791	4
2024-02-29	Foukas, Joshua	Officer	CHIEF LEGAL OFFICER	Direct	Sale	4,847	47.91	$232,219.77	0	4
2024-02-29	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	4,311	47.76	$205,893.36	7,825	4
2024-02-29	Pelosi, Peggie	Director	-	Direct	Sale	485	48.15	$23,352.75	3,138	4
2023-12-12	Fleming, John Turman	Director	-	Direct	Sale	312	49.73	$15,515.76	2,822	4
2023-11-03	Fuller, Gilbert A	Director	-	Direct	Sale	490	46.01	$22,544.90	0	4
2023-08-17	Winssinger, Frederic J	Director	-	Direct	Sale	930	63.84	$59,371.20	1,703	4
2023-08-15	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	2,159	65.34	$141,069.06	5,448	4
2023-08-11	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	1,080	66.28	$71,582.40	7,607	4
2023-08-01	Fuller, Gilbert A	Director	-	Direct	Sale	265	64.43	$17,073.95	0	4
2023-07-31	Fuller, Gilbert A	Director	-	Direct	Sale	226	65.01	$14,692.26	265	4
2023-07-31	Mulham, David Mulham	Officer	CHIEF SALES OFFICER	Direct	Sale	3,354	65.00	$218,010.00	8,687	4
2023-07-28	Jones, Paul A.	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	3,682	65.00	$239,330.00	3,353	4
2023-07-27	Ding, Xia	Director	-	Direct	Sale	606	65.60	$39,753.60	1,421	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

54.48%

Inst. Shares: 10,022,829

Shares Outstanding: 18,398,000

2025-12-31

55.60%

Inst. Shares: 10,305,596

Shares Outstanding: 18,535,000

2025-09-30

59.52%

Inst. Shares: 10,888,829

Shares Outstanding: 18,293,000

2025-06-30

58.23%

Inst. Shares: 10,779,786

Shares Outstanding: 18,513,000

2025-03-31

55.36%

Inst. Shares: 10,545,819

Shares Outstanding: 19,049,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	10,022,829	18,398,000	54.48%
2025-12-31	10,305,596	18,535,000	55.60%
2025-09-30	10,888,829	18,293,000	59.52%
2025-06-30	10,779,786	18,513,000	58.23%
2025-03-31	10,545,819	19,049,000	55.36%
2024-12-31	10,641,223	19,103,000	55.70%
2024-09-30	10,489,324	19,078,000	54.98%
2024-06-30	10,123,747	19,073,000	53.08%
2024-03-31	8,680,718	19,174,000	45.27%
2023-12-31	8,856,395	19,250,000	46.01%
2023-09-30	8,626,508	19,245,000	44.82%
2023-06-30	8,552,792	19,321,000	44.27%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

USANA HEALTH SCIENCES INC (USNA) — SEC Financial Statements & Analysis

USANA HEALTH SCIENCES INC (USNA) is a medicinal chemicals & botanical products company, incorporated in UT. USANA HEALTH SCIENCES INC trades on USNA: NYSE as: USNA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), USANA HEALTH SCIENCES INC reported a 5.67% year-over-year revenue growth, a Gross Profit Margin of 77.55% (TTM), a Debt-to-Equity ratio of 0.27x, a Price-to-Sales (P/S) ratio of 0.35x (TTM), a Price-to-Book (P/B) ratio of 0.59 (TTM), at a market cap of $321.41M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.67%
Gross Profit Margin TTM: 77.55%
Debt To Equity: 0.27x
P/S TTM: 0.35x
P/B TTM: 0.59
Market Cap: $321.41M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is USANA HEALTH SCIENCES INC in?

USANA HEALTH SCIENCES INC (USNA) operates in the Medicinal Chemicals & Botanical Products industry.

What is USNA's market cap?

USANA HEALTH SCIENCES INC (USNA) has a market capitalization of $321.41M as of 2026-03-31.

What is USNA's P/E ratio?

USANA HEALTH SCIENCES INC (USNA)'s trailing twelve month P/E ratio is 38.65x as of 2026-03-31.

What exchange does USNA trade on?

USANA HEALTH SCIENCES INC (USNA) trades on the USNA: NYSE.

Where is USANA HEALTH SCIENCES INC incorporated?

USANA HEALTH SCIENCES INC is incorporated in UT.

USANA HEALTH SCIENCES INC (USNA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.